LCMS webinars focusing on LC/QQQ - page 9

This presentation explores the use of deep learning models for LC-MS/MS MRM data processing in PFAS quantification, demonstrating improved integration accuracy and reduced manual data review.

Next-generation LC-MS detection delivers high sensitivity, wide mass range, and intelligent workflows for confident mass confirmation and purification in biopharma labs.

This study shows that dietary fructose accelerates tumor growth indirectly. AP-MALDI imaging and multi-omics MS reveal nutrient transfer mechanisms driving cancer metabolism.

This talk explores the discovery of novel oxylipins and 4-hydroxylated acylcarnitines, their regulation by diet and disease, and targeted LC-MS methods for low-abundance lipids.

AbbVie, MassTech, and Agilent present a new AP-MALDI QqQ platform, delivering up to 200× greater sensitivity for targeted imaging and drug analysis.

Discover how Nurix uses Agilent 6495 QqQ LC/MS MRM proteomics to quantify 45+ kinases, enabling high-throughput screening and degrader selectivity in TPD.

Molecular You combines multi-omic LC/MS/MS assays, AI, and clinical data to deliver predictive health insights, guide therapies, and advance personalized medicine.

Discover the GIGA assay: a fully automated LC/MS/MS workflow on Agilent 6495D that quantifies 2000+ metabolites in under 20 minutes, enabling next-gen metabolomics.

Integrated targeted and untargeted metabolomics using Agilent LC/MS reveals key CRC-associated serum changes, enhancing biomarker discovery potential.

Learn how HPLC/MS/MS quantifies hundreds of drugs from dried blood spots, with forensic data from 1,000+ paired DBS and urine samples using Agilent LC/QQQ.